Quantcast

Skin Lesion Identification System to Auction on November 11th at ICAP Ocean Tomo’s Fall 2010 Live IP Auction

September 14, 2010

CHICAGO, Sept. 14 /PRNewswire/ — ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L) and the world’s premier patent auction firm, will auction technology related to skin lesion detection and classification at the upcoming Fall 2010 Live Auction in Napa, California on November 11th.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)

In the US, nearly 2.5 million patients are treated each year for skin lesions such as pressure ulcers, and approximately 60,000 patients die from related complications.(1) Traditional treatment includes regular monitoring of the skin lesion by medical professionals, however, this technique has several disadvantages such as human error and the high cost of labor required to administer treatment. The assets of this lot disclose a system that provides for highly efficient, accurate, and cost effective monitoring of skin lesions. Comprised of a camera, processor, and reporting device, the system identifies and classifies skin lesions as well as evaluates the effectiveness of the treatment. The camera in the system captures a two-dimensional image of the skin lesion which is then sent to the processor and converted into a three-dimensional image. The converted image can be compared to previously stored images to track the effectiveness of treatment. As the system relies on electronic comparisons, it generates highly accurate results. In addition, the electronic nature of the stored data provides for easy storage and transfer to remote locations for reporting.

“Lesions can be treated by several methods with varying degrees of effectiveness in different patients. It is important to determine the most suitable treatment for each patient as fast as possible because in addition to reducing patient’s suffering, in case of pressure ulcers, care providers suffer regulatory financial consequences and bad reputation related to lesion’s frequency and duration,” said co-inventor Dr. Josef Osterweil. “The accuracy of our system, with or without mining, allows the user to detect the smallest changes of the lesion thus allowing rapid adjustment of treatment.”

The cost of treatment for skin lesions such as pressure ulcers in the US is estimated to be $11 billion per year.(2) “This lot should be of interest to medical device manufacturers, health care service providers, insurance companies, and other entities operating in the healthcare field,” said Dean Becker, ICAP Ocean Tomo CEO.

Experimental equipment and data is available upon request. To learn more about this lot and how to participate in the Fall Live Auction please contact Dean Becker at Dean.Becker@us.icap.com.

To view the full Fall Auction Catalog visit www.icapoceantomo.com/auction/fall/catalog.

1 & 2 http://www.medline.com/programs/pressure-ulcer-prevention-program/

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world’s premier patent auction firm.

About ICAP

ICAP is the world’s premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.

SOURCE ICAP Ocean Tomo


Source: newswire



comments powered by Disqus